Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Anjaneyulu Dirisala"'
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Externí odkaz:
https://doaj.org/article/e91e9f63da314542890a91f8016c2776
Autor:
P. K. Hashim, Anjaneyulu Dirisala
Publikováno v:
Bionanotechnology in Cancer ISBN: 9780429422911
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbb3c8fc6884c0d3b9e036a0466d8a18
https://doi.org/10.1201/9780429422911-10
https://doi.org/10.1201/9780429422911-10
Publikováno v:
Advanced Drug Delivery Reviews. 198:114895
Autor:
Sayoni Maitra Roy, Vrinda Garg, Sushmitha Pedugu Sivaraman, Sourav Barman, Chitrita Ghosh, Pousali Bag, Palanivelmurugan Mohanasundaram, Partha Sona Maji, Arnab Basu, Anjaneyulu Dirisala, Surya K. Ghosh, Amit Ranjan Maity
Publikováno v:
Journal of Drug Delivery Science and Technology. 83:104408
Autor:
Kazunori Kataoka, Anjaneyulu Dirisala, Saed Abbasi, Kotaro Hayashi, Theofilus A. Tockary, Satoshi Uchida, Shigeto Fukushima, Kazuko Toh
Publikováno v:
Journal of Controlled Release. 332:260-268
Genome editing using CRISPR/Cas9 has attracted considerable attention for the treatment of genetic disorders and viral infections. Co-delivery of Cas9 mRNA and single guide (sg)RNA is a promising strategy to efficiently edit the genome of various cel
Autor:
Anjaneyulu Dirisala, Yasutaka Anraku, Xueying Liu, Theofilus A. Tockary, Kazunori Kataoka, Kazuko Toh, Daniel Gonzalez-Carter
Publikováno v:
Proc Natl Acad Sci U S A
Current strategies to direct therapy-loaded nanoparticles to the brain rely on functionalizing nanoparticles with ligands which bind target proteins associated with the blood-brain barrier (BBB). However, such strategies have significant brain-specif
Autor:
Kazuko Toh, Tao Yang, Zengtao Wang, Shigeto Fukushima, Junjie Li, Takanori Yokota, Kazunori Kataoka, Yonger Xue, Sabina Quader, Anjaneyulu Dirisala, Xueying Liu, Jinbing Xie, Nakamura Noriko, Kouhei Tsumoto, Yasutaka Anraku, Makoto Nakakido, Daniel Gonzalez-Carter, Hiroki Akiba, Theofilus A. Tockary
Publikováno v:
ACS Nano. 14:6729-6742
Delivering therapeutic antibodies into the brain across the blood-brain barrier at a therapeutic level is a promising while challenging approach in the treatment of neurological disorders. Here, we present a polymeric nanomicelle (PM) system capable
Autor:
Naoto Yoshinaga, Satoshi Uchida, Anjaneyulu Dirisala, Mitsuru Naito, Kyoko Koji, Kensuke Osada, Horacio Cabral, Kazunori Kataoka
Publikováno v:
Advanced healthcare materials. 11(9)
Polyplex for messenger RNA (mRNA) delivery requires strong yet reversible association between mRNA and polycation for extracellular robustness and selective intracellular disintegration. Herein, RNA oligonucleotide (OligoRNA) derivatives that bridge
Autor:
Panyue Wen, Joachim F R Van Guyse, Zheng Wang, Yasutaka Anraku, Kazuko Toh, Jinbing Xie, Hiroaki Kinoh, Theofilus A. Tockary, Hang Zhou, Kazunori Kataoka, Daniel Gonzalez-Carter, Anjaneyulu Dirisala, Xueying Liu, Shiyan Xiao, Zhishen Ge, Satoshi Uchida, Wendong Ke, Junjie Li
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 33(49)
Prevention of metastatic and local-regional recurrence of cancer after surgery remains difficult. Targeting postsurgical premetastatic niche and microresiduals presents an excellent prospective opportunity but is often challenged by poor therapeutic
Autor:
Pengwen Chen, Wenqian Yang, Taehun Hong, Takuya Miyazaki, Anjaneyulu Dirisala, Kazunori Kataoka, Horacio Cabral
Publikováno v:
Biomaterials. 288:121748
Intracellular protein delivery is a powerful strategy for developing innovative therapeutics. Nanocarriers present great potential to deliver proteins inside cells by promoting cellular uptake and overcoming entrapment and degradation in acidic endo/